A Study of a Urine Test to Detect Colorectal Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.
Eligibility criteria
Qualifiers
Patients with symptoms of CRC (such as rectal bleeding for a week) -OR-
Patients who present for a screening colonoscopy -OR-
Has received one of the following within 3 weeks of the planned urine collection
Patients with a pathologic diagnosis of CRC either by colonoscopy or resection specimens -OR-
Disqualifiers
None
Trial design
Treatments tested in this trial
- 3-metabolite biosensor
Treatment groups
210 Participants
are divided into 1 treatment groupLocations
4Ghana
Korle Bu Teaching Hospital (Data Collection Only) Accra Ghana
South Africa
Wits Donald Gordon Medical Centre (Data Collection Only) Johannesburg South Africa
Tanzania
Kilimanjaro Christian Medical Centre (Data Collection Only) Moshi Tanzania
United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)10065, New YorkNew York, United States
Sponsors and collaborators
Memorial Sloan Kettering Cancer Center
Lead sponsor
Source ClinicalTrials.gov